S&P Global Closes $1B Senior Notes (2031, 2035)

S&P Global completed a private placement of senior notes totaling $1.0 billion, with maturities falling in 2031 and 2035. According to the company timeline, the notes were priced and issued on Dec. 1, 2025 and the transaction closed on Dec. 4, 2025. The company’s 8-K/related disclosures in the provided record do not specify interest rates, security features, or a stated use of proceeds for the offering, so those details are not available in the supplied materials. The private placement structure and staggered maturities indicate a preference for multi-term liability management, but the filings and supplied notes do not state whether the notes replace existing debt, fund general corporate purposes, or support capital return programs. Investors seeking coupon, covenants, or trustee details will need to consult the company’s formal offering documents or subsequent SEC filings beyond the provided records.

S&P Global enters this financing against a 9-month 2025 financial backdrop of $11,420 million in revenue (up 7.6% year over year) and $3,596 million in net income (up 12.4% YoY). Q3 2025 revenue was $3,888 million (+8.8% YoY). Liquidity on the balance sheet shows cash and cash equivalents of $1,672 million for the nine months ended Sept. 30, 2025; total assets were $59,749 million and total equity was $33,238 million for the same period. The filings note elevated amortization expense ($803 million for 9M 2025) related to prior acquisitions, which the company flags as an operational consideration. The new senior notes add to S&P Global’s debt maturity profile; absent specific use-of-proceeds language in the provided documents, the immediate balance-sheet impact is an increase in long-term liabilities offset by receipt of gross proceeds. Management transitions over the prior year (including the Nov. 1, 2024 CEO change and executive-level departures and appointments in early 2025) and a recently authorized capital-return program (see Historical Context) are relevant for investors assessing capital-allocation strategy alongside this debt move.

Key follow-ups for investors include: any supplemental disclosures or 8-Ks that detail coupon, covenants, trustee or collateral (if any); explicit use-of-proceeds language; and the company’s near-term debt schedule as updated in subsequent filings. Given management’s recent activity on capital allocation, including a separate share-repurchase authorization, watchers should monitor whether proceeds support buybacks, refinancing, or corporate investments. The company’s segment reporting in its recent 10-Qs does not provide a granular revenue split by segment or geography, so investors will need to rely on management commentary in future filings for segment-level drivers tied to capital deployment decisions.